AbbVie Operating Income 2010-2024 | ABBV

AbbVie operating income for the twelve months ending December 31, 2024 was $9.137B, a 28.38% decline year-over-year.

  • AbbVie annual operating income for 2024 was $9.137B, a 28.38% decline from 2023.
  • AbbVie annual operating income for 2023 was $12.757B, a 29.59% decline from 2022.
  • AbbVie annual operating income for 2022 was $18.117B, a 1.08% increase from 2021.

AbbVie Operating Income 2010-2024 | ABBV

  • AbbVie annual operating income for 2024 was $9.137B, a 28.38% decline from 2023.
  • AbbVie annual operating income for 2023 was $12.757B, a 29.59% decline from 2022.
  • AbbVie annual operating income for 2022 was $18.117B, a 1.08% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B